Stock Fundamentals

Company Information

Company Name
Kodiak Sciences Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US50015M1099
CIK: 0001468748
CUSIP: 50015M109
Currency: USD
Full Time Employees: 130
Phone: 650 281 0850
Fiscal Year End: December
IPO Date: Oct 04, 2018
Description:

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Address:

1250 Page Mill Road, Palo Alto, CA, United States, 94304

Directors & Officers

Name Title Year Born
Dr. Victor Perlroth M.D. Co-Founder, Chairman, CEO & President 1974
Mr. John A. Borgeson CPA, M.B.A. Executive VP, CFO & Secretary 1963
Mr. Wayne To M.Phil. Chief Technology Officer NA
Dr. Dolly S. Chang M.D., M.P.H., Ph.D. Chief Scientific Officer NA
Dr. Hong Liang Ph.D. Senior Vice President of Development 1972
Dr. Stephen Raillard Ph.D. Senior Vice President of Chemical Development & Manufacturing NA
Ms. Almas Qudrat M.Sc. Chief Quality Officer NA
Dr. J. Pablo Velazquez-Martin M.D. Chief Medical Officer NA
Dr. Laurent Ducay Ph.D. Senior VP of Biologics Development & Manufacturing NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 18, 2025 Bros. Advisors Lp Baker N/A Purchase 2.61M $23.00 $60.00M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 19.92M Mar 31, 2026 31.83% $4.36 0.00%
BlackRock Inc 3.94M Mar 31, 2026 6.29% $0.00 -0.49%
Vanguard Group Inc 2.31M Dec 31, 2025 3.70% $0.00 18.62%
State Street Corp 2.25M Mar 31, 2026 3.60% $0.00 29.96%
T. Rowe Price Associates, Inc. 2.04M Mar 31, 2026 3.26% $0.01 74.28%
BRAIDWELL LP 1.82M Mar 31, 2026 2.91% $2.31 -12.26%
Vanguard Capital Management, LLC 1.72M Mar 31, 2026 2.74% $0.00 0.00%
The Goldman Sachs Group Inc 1.69M Mar 31, 2026 2.70% $0.01 29.62%
RTW INVESTMENTS, LLC 1.49M Mar 31, 2026 2.38% $0.56 0.00%
TCG Crossover Management, LLC 1.45M Mar 31, 2026 2.31% $1.58 0.00%
Boxer Capital Management, LLC 1.36M Mar 31, 2026 2.17% $6.81 19.81%
HHG PLC 1.33M Mar 31, 2026 2.12% $0.02 32.55%
ICONIQ Capital, LLC 1.27M Mar 31, 2026 2.02% $1.08 0.00%
Ikarian Capital, LLC 1.27M Mar 31, 2026 2.02% $3.92 75.86%
Geode Capital Management, LLC 1.00M Mar 31, 2026 1.60% $0.00 11.44%
SILVERARC CAPITAL MANAGEMENT, LLC 991.93K Mar 31, 2026 1.59% $3.86 -3.05%
Citadel Advisors Llc 870.79K Mar 31, 2026 1.39% $0.01 199.78%
T. Rowe Price Investment Management,Inc. 836.94K Mar 31, 2026 1.34% $0.02 98.17%
Balyasny Asset Management LLC 726.55K Mar 31, 2026 1.16% $0.04 175.96%
Board of Ttees Leland Stanford Jr Univ 691.77K Mar 31, 2026 1.11% $3.11 0.00%

Shares Statistics

Shares Outstanding: 62.58M
Shares Float: 39.28M
% Insiders: 518.40%
% Institutions: 9,956.30%
Short % Float: 26.16%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 State Street® SPDR® S&P® Biotech ETF 1.49M 2.38% ▼ 0.61% May 31, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.26M 2.02% ▲ 2.83% Apr 30, 2026
3 iShares Russell 2000 ETF 906.37K 1.45% ▲ 0.93% May 29, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 453.42K 0.72% ▲ 0.92% Apr 30, 2026
5 iShares Biotechnology ETF 417.91K 0.67% ▲ 1.34% May 29, 2026
6 Artisan International Small-Mid Investor 407.93K 0.65% ▼ 20.95% Mar 31, 2026
7 Artisan Non-U.S. Small-Mid Growth Comp 407.93K 0.65% ▼ 20.95% Mar 31, 2026
8 Fidelity Small Cap Index 371.01K 0.59% ▲ 15.80% Mar 31, 2026
9 iShares Russell 2000 Value ETF 330.65K 0.53% ▲ 1.37% May 29, 2026
10 T. Rowe Price New Horizons 316.22K 0.51% ▲ 17.27% Apr 30, 2026

Valuation Metrics

Enterprise Value: $2.02B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $2.13B
EBITDA: $-219.17M
Book Value: $1.81
Earnings/Share: $-4.17
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -49.06%
ROE (TTM): -208.80%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.72x 0.08x 0.55x N/A -0.06x
2024-12-31 6.72x 0.07x 0.55x N/A -0.07x
2023-12-31 6.93x 0.04x 0.45x -21,332.38x -0.04x
2022-12-31 9.26x 0.02x 0.35x -18,965.50x -0.03x
2021-12-31 11.36x 0.01x 0.27x -12,138.68x -0.02x
2020-12-31 30.93x 0.00x 0.19x -5,440.28x -0.02x
2019-12-31 28.97x 0.00x 0.04x -6,148.75x -0.01x
2018-12-31 18.74x 0.00x 0.06x -4.78x 0.00x
2017-12-31 0.17x -0.15x 22.19x -21.54x -0.38x
2016-12-31 4.06x 0.00x 4.39x -2,858.50x -0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KOD.US!